鸡尾酒-话题@MedSci

#鸡尾酒#

57篇内容 | 1098人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1574800, encodeId=988c15e4800e5, content=<a href='/topic/show?id=da8110295622' target=_blank style='color:#2F92EE;'>#鸡尾酒#</a>, objectTitle=吉利德HIV鸡尾酒疗法获FDA批准，年销售超10亿美元指日可待, objectType=article, longId=64513, objectId=3b0b645131a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b0b645131a, replyNumber=0, likeNumber=36, createdTime=2016-03-10, rootId=0, userName=qblt, userId=519516025516, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b0b645131a, moduleTitle=吉利德HIV鸡尾酒疗法获FDA批准，年销售超10亿美元指日可待, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3b0b645131a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1574799, encodeId=daf115e479925, content=<a href='/topic/show?id=da8110295622' target=_blank style='color:#2F92EE;'>#鸡尾酒#</a>, objectTitle=超级重磅！百时美全口服丙肝鸡尾酒daclatasvir+asunaprevir中国丙肝III期临床获得成功, objectType=article, longId=63843, objectId=fe1b6384351, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe1b6384351, replyNumber=0, likeNumber=37, createdTime=2016-02-28, rootId=0, userName=qblt, userId=519516025516, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe1b6384351, moduleTitle=超级重磅！百时美全口服丙肝鸡尾酒daclatasvir+asunaprevir中国丙肝III期临床获得成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe1b6384351)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1574798, encodeId=c8df15e479865, content=<a href='/topic/show?id=da8110295622' target=_blank style='color:#2F92EE;'>#鸡尾酒#</a>, objectTitle=吉利德泛基因型丙肝鸡尾酒疗法SOF/VEL获FDA优先审查资格，将极大简化丙肝临床治疗, objectType=article, longId=61804, objectId=93ed618041a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=93ed618041a, replyNumber=0, likeNumber=24, createdTime=2016-01-09, rootId=0, userName=qblt, userId=519516025516, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=93ed618041a, moduleTitle=吉利德泛基因型丙肝鸡尾酒疗法SOF/VEL获FDA优先审查资格，将极大简化丙肝临床治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=93ed618041a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1574797, encodeId=135815e479702, content=<a href='/topic/show?id=da8110295622' target=_blank style='color:#2F92EE;'>#鸡尾酒#</a>, objectTitle=Cell stem cell：小分子“鸡尾酒”让星形胶质细胞变身功能神经元, objectType=article, longId=57555, objectId=7f255e55509, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7f255e55509, replyNumber=0, likeNumber=36, createdTime=2015-10-23, rootId=0, userName=qblt, userId=519516025516, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7f255e55509, moduleTitle=Cell stem cell：小分子“鸡尾酒”让星形胶质细胞变身功能神经元, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7f255e55509)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1574796, encodeId=4b2315e4796df, content=<a href='/topic/show?id=da8110295622' target=_blank style='color:#2F92EE;'>#鸡尾酒#</a>, objectTitle=Cell Res：化学鸡尾酒将小鼠成纤维细胞直接重编程为心肌细胞, objectType=article, longId=55321, objectId=5bfd553217d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5bfd553217d, replyNumber=0, likeNumber=26, createdTime=2015-08-27, rootId=0, userName=qblt, userId=519516025516, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5bfd553217d, moduleTitle=Cell Res：化学鸡尾酒将小鼠成纤维细胞直接重编程为心肌细胞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5bfd553217d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1574795, encodeId=7edd15e4795e4, content=<a href='/topic/show?id=da8110295622' target=_blank style='color:#2F92EE;'>#鸡尾酒#</a>, objectTitle=艾伯维丙肝鸡尾酒Viekira Pak治疗肝硬化1b型丙肝实现100%治愈率, objectType=article, longId=52528, objectId=b72b52528ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b72b52528ea, replyNumber=0, likeNumber=29, createdTime=2015-06-28, rootId=0, userName=qblt, userId=519516025516, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b72b52528ea, moduleTitle=艾伯维丙肝鸡尾酒Viekira Pak治疗肝硬化1b型丙肝实现100%治愈率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b72b52528ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1574794, encodeId=b3f715e47942b, content=<a href='/topic/show?id=da8110295622' target=_blank style='color:#2F92EE;'>#鸡尾酒#</a>, objectTitle=降糖减肥双获益，糖尿病鸡尾酒欧盟上市, objectType=article, longId=46252, objectId=0e1046252ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e1046252ab, replyNumber=0, likeNumber=30, createdTime=2015-01-29, rootId=0, userName=qblt, userId=519516025516, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e1046252ab, moduleTitle=降糖减肥双获益，糖尿病鸡尾酒欧盟上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0e1046252ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1574793, encodeId=93ab15e479327, content=<a href='/topic/show?id=da8110295622' target=_blank style='color:#2F92EE;'>#鸡尾酒#</a>, objectTitle=PD-1/PD-L1领域竞争加剧：百时美联手2家日企开发免疫鸡尾酒Opdivo/mogamulizumab, objectType=article, longId=44001, objectId=f44c44001b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f44c44001b8, replyNumber=0, likeNumber=33, createdTime=2014-12-14, rootId=0, userName=qblt, userId=519516025516, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f44c44001b8, moduleTitle=PD-1/PD-L1领域竞争加剧：百时美联手2家日企开发免疫鸡尾酒Opdivo/mogamulizumab, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f44c44001b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1574792, encodeId=ec4515e4792d2, content=<a href='/topic/show?id=da8110295622' target=_blank style='color:#2F92EE;'>#鸡尾酒#</a>, objectTitle=癌症疫苗迎来转机：安进&默沙东合作开发癌症免疫鸡尾酒T-vec/Keytruda, objectType=article, longId=43905, objectId=b8314390543, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b8314390543, replyNumber=0, likeNumber=34, createdTime=2014-12-13, rootId=0, userName=qblt, userId=519516025516, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b8314390543, moduleTitle=癌症疫苗迎来转机：安进&默沙东合作开发癌症免疫鸡尾酒T-vec/Keytruda, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b8314390543)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1574791, encodeId=ea2d15e4791c8, content=<a href='/topic/show?id=da8110295622' target=_blank style='color:#2F92EE;'>#鸡尾酒#</a>, objectTitle=喜大普奔！吉利德丙肝鸡尾酒Harvoni获FDA批准！, objectType=article, longId=41187, objectId=3e0f4118ec0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3e0f4118ec0, replyNumber=0, likeNumber=33, createdTime=2014-10-15, rootId=0, userName=qblt, userId=519516025516, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3e0f4118ec0, moduleTitle=喜大普奔！吉利德丙肝鸡尾酒Harvoni获FDA批准！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3e0f4118ec0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1574790, encodeId=f63315e4790b8, content=<a href='/topic/show?id=da8110295622' target=_blank style='color:#2F92EE;'>#鸡尾酒#</a>, objectTitle=肝福音——吉利德丙肝鸡尾酒LDV/SOF年底在欧美上市, objectType=article, longId=40986, objectId=58734098676, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=58734098676, replyNumber=0, likeNumber=26, createdTime=2014-10-10, rootId=0, userName=qblt, userId=519516025516, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=58734098676, moduleTitle=肝福音——吉利德丙肝鸡尾酒LDV/SOF年底在欧美上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=58734098676)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1574789, encodeId=1e9f15e47899d, content=<a href='/topic/show?id=da8110295622' target=_blank style='color:#2F92EE;'>#鸡尾酒#</a>, objectTitle=吉利德丙肝地位撼动——百时美丙肝新药Daklinza获欧盟批准——鸡尾酒治愈率达100%, objectType=article, longId=39744, objectId=afa239e4413, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=afa239e4413, replyNumber=0, likeNumber=31, createdTime=2014-08-31, rootId=0, userName=qblt, userId=519516025516, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=afa239e4413, moduleTitle=吉利德丙肝地位撼动——百时美丙肝新药Daklinza获欧盟批准——鸡尾酒治愈率达100%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=afa239e4413)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1574788, encodeId=756615e47880e, content=<a href='/topic/show?id=da8110295622' target=_blank style='color:#2F92EE;'>#鸡尾酒#</a>, objectTitle=Aduro癌症免疫鸡尾酒疗法获得FDA突破性药物认证, objectType=article, longId=38140, objectId=b5be38140c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b5be38140c7, replyNumber=0, likeNumber=43, createdTime=2014-07-24, rootId=0, userName=qblt, userId=519516025516, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b5be38140c7, moduleTitle=Aduro癌症免疫鸡尾酒疗法获得FDA突破性药物认证, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b5be38140c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1574787, encodeId=94fc15e478772, content=<a href='/topic/show?id=da8110295622' target=_blank style='color:#2F92EE;'>#鸡尾酒#</a>, objectTitle=EBC 2014：新型鸡尾酒疗法可改善胰腺癌治疗, objectType=article, longId=34162, objectId=32603416240, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=32603416240, replyNumber=0, likeNumber=43, createdTime=2014-05-06, rootId=0, userName=qblt, userId=519516025516, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=32603416240, moduleTitle=EBC 2014：新型鸡尾酒疗法可改善胰腺癌治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=32603416240)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1574786, encodeId=489e15e47863c, content=<a href='/topic/show?id=da8110295622' target=_blank style='color:#2F92EE;'>#鸡尾酒#</a>, objectTitle=默沙东丙肝鸡尾酒MK-5172/MK-8742初治群体治愈率近100%, objectType=article, longId=33223, objectId=6396332239a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6396332239a, replyNumber=0, likeNumber=24, createdTime=2014-04-13, rootId=0, userName=qblt, userId=519516025516, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6396332239a, moduleTitle=默沙东丙肝鸡尾酒MK-5172/MK-8742初治群体治愈率近100%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6396332239a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1574785, encodeId=578015e4785b9, content=<a href='/topic/show?id=da8110295622' target=_blank style='color:#2F92EE;'>#鸡尾酒#</a>, objectTitle=百时美丙肝鸡尾酒疗法DCV/ASV III期治愈率达90%, objectType=article, longId=33222, objectId=bfe733222a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bfe733222a0, replyNumber=0, likeNumber=32, createdTime=2014-04-13, rootId=0, userName=qblt, userId=519516025516, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bfe733222a0, moduleTitle=百时美丙肝鸡尾酒疗法DCV/ASV III期治愈率达90%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bfe733222a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1574784, encodeId=461015e478422, content=<a href='/topic/show?id=da8110295622' target=_blank style='color:#2F92EE;'>#鸡尾酒#</a>, objectTitle=AbbVie丙肝鸡尾酒疗法III期研究治愈率近100%, objectType=article, longId=31517, objectId=aa363151e18, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aa363151e18, replyNumber=0, likeNumber=26, createdTime=2014-03-07, rootId=0, userName=qblt, userId=519516025516, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aa363151e18, moduleTitle=AbbVie丙肝鸡尾酒疗法III期研究治愈率近100%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aa363151e18)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

鸡尾酒

2020-05-29

qblt (审核中...)

前往app查看评论内容

#鸡尾酒#

吉利德HIV鸡尾酒疗法获FDA批准，年销售超10亿美元指日可待

2016-03-10

qblt (审核中...)

前往app查看评论内容

#鸡尾酒#

超级重磅！百时美全口服丙肝鸡尾酒daclatasvir+asunaprevir中国丙肝III期临床获得成功

2016-02-28

qblt (审核中...)

前往app查看评论内容

#鸡尾酒#

吉利德泛基因型丙肝鸡尾酒疗法SOF/VEL获FDA优先审查资格，将极大简化丙肝临床治疗

2016-01-09

qblt (审核中...)

前往app查看评论内容

#鸡尾酒#

Cell stem cell：小分子“鸡尾酒”让星形胶质细胞变身功能神经元

2015-10-23

qblt (审核中...)

前往app查看评论内容

#鸡尾酒#

Cell Res：化学鸡尾酒将小鼠成纤维细胞直接重编程为心肌细胞

2015-08-27

qblt (审核中...)

前往app查看评论内容

#鸡尾酒#

艾伯维丙肝鸡尾酒Viekira Pak治疗肝硬化1b型丙肝实现100%治愈率

2015-06-28

qblt (审核中...)

前往app查看评论内容

#鸡尾酒#

降糖减肥双获益，糖尿病鸡尾酒欧盟上市

2015-01-29

qblt (审核中...)

前往app查看评论内容

#鸡尾酒#

PD-1/PD-L1领域竞争加剧：百时美联手2家日企开发免疫鸡尾酒Opdivo/mogamulizumab

2014-12-14

qblt (审核中...)

前往app查看评论内容

#鸡尾酒#

癌症疫苗迎来转机：安进&默沙东合作开发癌症免疫鸡尾酒T-vec/Keytruda

2014-12-13

qblt (审核中...)

前往app查看评论内容

#鸡尾酒#

喜大普奔！吉利德丙肝鸡尾酒Harvoni获FDA批准！

2014-10-15

qblt (审核中...)

前往app查看评论内容

#鸡尾酒#

肝福音——吉利德丙肝鸡尾酒LDV/SOF年底在欧美上市

2014-10-10

qblt (审核中...)

前往app查看评论内容

#鸡尾酒#

吉利德丙肝地位撼动——百时美丙肝新药Daklinza获欧盟批准——鸡尾酒治愈率达100%

2014-08-31

qblt (审核中...)

前往app查看评论内容

#鸡尾酒#

Aduro癌症免疫鸡尾酒疗法获得FDA突破性药物认证

2014-07-24

qblt (审核中...)

前往app查看评论内容

#鸡尾酒#

EBC 2014：新型鸡尾酒疗法可改善胰腺癌治疗

2014-05-06

qblt (审核中...)

前往app查看评论内容

#鸡尾酒#

默沙东丙肝鸡尾酒MK-5172/MK-8742初治群体治愈率近100%

2014-04-13

qblt (审核中...)

前往app查看评论内容

#鸡尾酒#

百时美丙肝鸡尾酒疗法DCV/ASV III期治愈率达90%

2014-04-13

qblt (审核中...)

前往app查看评论内容

#鸡尾酒#

AbbVie丙肝鸡尾酒疗法III期研究治愈率近100%

2014-03-07

科室
- - 订阅+
  - 更多科室
工具
服务